USFDA makes 'certain' observations for Torrent Pharma's Indrad plant

The audit at Indrad plant of the company was carried out by the United States Food and Drug Administration (USFDA) in April.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news